Evidence map›Paper›PMID 33750029›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2021

Eosinophil ETosis-Mediated Release of Galectin-10 in Eosinophilic Granulomatosis With Polyangiitis.

Mineyo Fukuchi, Yosuke Kamide, Shigeharu Ueki, Yui Miyabe, Yasunori Konno, Nobuyuki Oka, Hiroki Takeuchi, Souichi Koyota, Makoto Hirokawa, Takechiyo Yamada and 3 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. AlEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Eosinophil ETosis and Charcot-Leyden crystals in Kimura disease.The journal of allergy and clinical immunology. Global · 2025
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Mineyo FukuchiAkita University, Akita, Japan.ORCID 0000-0002-1161-9074
Yosuke KamideSagamihara National Hospital, Kanagawa, Japan.ORCID 0000-0002-7185-2273
Shigeharu UekiAkita University, Akita, Japan.ORCID 0000-0002-3537-7735
Yui MiyabeAkita University, Akita, Japan.ORCID 0000-0003-0819-1625
Yasunori KonnoAkita University, Akita, Japan.
Nobuyuki OkaKyoto Konoe Rehabilitation Hospital, Kyoto, Japan.
Hiroki TakeuchiKyoto Minami Hospital, Kyoto, Japan.
Souichi KoyotaAkita University, Akita, Japan.
Makoto HirokawaAkita University, Akita, Japan.
Takechiyo YamadaAkita University, Akita, Japan.
Rossana C N MeloFederal University of Juiz de Fora, Juiz de Fora, Brazil, and Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States.ORCID 0000-0003-1736-0806
Peter F WellerBeth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States.
Masami TaniguchiSagamihara National Hospital, Kanagawa, Japan.
Akita University · JPKyoto City Hospital · JPNational Sagamihara Hospital · JPBeth Israel Deaconess Medical Center · USUniversidade Federal de Juiz de Fora · BR

Funding

Human Eosinophils: Mechanisms of FunctioningR37AI020241 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WELLER, PETER F · 2010 to 2019
$4.5M
NIAID NIH HHS R37 AI020241
6 · The paper itself

Abstract

objectiveEosinophils are tissue-dwelling immune cells. Accumulating evidence indicates that a type of cell death termed ETosis is an important cell fate involved in the pathophysiology of inflammatory diseases. Although the critical role of eosinophils in eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss syndrome) is well established, the presence of eosinophil ETosis (EETosis) is poorly understood. We undertook this study to better understand the characteristics of EETosis.

methodsIn vitro studies using blood-derived eosinophils were conducted to characterize EETosis. The occurrence of EETosis in tissues from patients with EGPA was studied by immunostaining and electron microscopy. Serum concentrations of eosinophil-derived proteins in healthy controls, patients with asthma, and EGPA patients with active disease or with disease in remission (n = 15 per group) were examined.

resultsEETosis was reliant on reactive oxygen species and peptidylarginine deiminase type 4-dependent histone citrullination, resulting in the cytolytic release of net-like eosinophil extracellular traps, free galectin-10, and membrane-bound intact granules. The signature of EETosis, including loss of cytoplasmic galectin-10 and deposition of granules, was observed in eosinophils infiltrating various tissues from EGPA patients. Serum eosinophil granule proteins and galectin-10 levels were increased in EGPA and positively correlated with disease activity as assessed by the Birmingham Vasculitis Activity Score (r = 0.8531, P < 0.0001 for galectin-10). When normalized to blood eosinophil counts, this correlation remained for galectin-10 (r = 0.7168, P < 0.0001) but not for granule proteins. Galectin-10 levels in active EGPA positively correlated with serum interleukin-5 levels.

conclusionEosinophils infiltrating diseased tissues in EGPA undergo EETosis. Considering the exclusive expression and large pool of cytoplasmic galectin-10 in eosinophils, elevated serum galectin-10 levels in patients with EGPA might reflect the systemic occurrence of cytolytic EETosis.

Indexed as

AdultAgedCell DeathEosinophilsFemaleGalectinsGranulomatosis with PolyangiitisHumansMaleMiddle AgedReactive Oxygen Speciesgalectin 10, humanGalectinsReactive Oxygen Species

Identifiers

PMID33750029
PMCPMC8403105
OpenAlexW3136390742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.